Hormonal health
Short-term bets, long-term needs: Rethinking investment in women’s health
Short-term bets, long-term needs: Rethinking investment in women’s health
By Morgan Rose, CNM, WHNP-BC, IBCLC | Chief Science Officer, Ema
Most investors treat women’s health as a series of disconnected markets. One fund backs cycle tracking. Another backs a postpartum platform. A third takes a bet on menopause.
While women experience distinct life stages, they progress through them in a continuous and interconnected way. A fertility journey may follow years of hormonal birth control.
Postpartum mental health may trigger a return of PMDD. Perimenopause may intensify autoimmune symptoms that a woman’s been tracking since adolescence. It’s all one story.
The system just isn’t built to integrate it.
This is how women end up using three separate apps with three different symptom logs, none of which communicate with each other. They repeat themselves to the system over and over.
Their data is siloed. Their emotional context is lost. Their trust in digital health wears thin.
And that’s more than a user experience problem; it’s a clinical one. Tech built and funded to support women must be designed with that reality in mind.
At Ema, we built the first agentic AI layer, purpose-built for women’s health, designed to understand her history, hormonal shifts, emotional context, and clinical risk in real-time.
It’s more than conversation. It’s care that connects.
Our AI supports users across fertility, postpartum, and menopause, treating these life stages as interconnected rather than isolated experiences.
But the real value lies in backing AI that connects, adapts, and scales with her across life stages, from puberty to postmenopause.
And we’ve raised over $3M from investors like Emmeline Ventures, Kubera Venture Capital, Hearst Labs, Acumen America, and Techstars to prove there is an investor market for longitudinal and connected care.
Why AI Is Not Just Another Point Solution
The opportunity lies in building AI that carries memory, recognises emotional and hormonal patterns, and supports women through years of shifting health needs, not just to accelerate answers, but to sustain care and improve health outcomes.
Women don’t need 10 tools for 10 life stages. They need one layer of intelligence that knows their history and evolves with them.
That requires AI trained on longitudinal, women-centered data.
It means remembering the postpartum depression that followed a second child, the cycle shifts after an IUD change, and the miscarriage before a new fertility journey.
Naseem Sayani is Director of the Innovator’s Circle at Women’s Health Access Matters, Operating Advisor at How Women Invest, and Advisor at Tower Capital.
She said: “The opportunity at the intersection of women’s health and AI is not just about smarter in-the-moment insights – we’re talking about more advanced everyday care, and an industry wide transformation from anecdote-based care to actual data-based care.
“Small models will become more important than large models, and with higher investment in these innovations, we can enable a Black mom in California avoid preeclampsia; a South Asian teenage girl in New Jersey understand her culture’s predisposition for endometriosis; and a Caucasian woman in Missouri chose birth control that helps her avoid her family’s history of cardiac disease.
“This interconnected healthcare transformation is at our fingertips.”
Investing in AI for women’s health is how we finally build continuity into a system that’s been fractured for too long.
The Silo Problem: Funding Symptoms, Not Systems
AI in healthcare is booming. The market is projected to hit $431 billion by 2032, driven by LLMs, workflow automation, and AI-first platforms.
Meanwhile, investment in women’s health hit a record $2.6 billion in 2024, and up to $10.7 billion when you include conditions that disproportionately affect women, from autoimmune disease to chronic fatigue.
So why is so little capital flowing to the intersection of AI and women’s health?
Because most AI funders still look for large, generalisable models. And most women’s health funders are still thinking in point solutions.
Very few are investing in vertically integrated AI designed to understand complex, longitudinal, and emotionally nuanced care.
The short-term thinking that drives product silos also shapes where capital flows. Investors back tools that solve for isolated needs, in isolated moments, without asking how those tools will connect, carry forward context, or scale with a woman’s life.
And nowhere is that pattern more evident than in the current landscape of AI investment.
A Call to Investors
If you’re funding the next wave of women’s health innovation, ask what it’s built on.
If the product doesn’t carry memory, adapt to complexity, or unify care across her lifespan, then it’s not future-proof. Let others chase features. Let’s build the foundation they’ll all need to run on.
Ema is raising now. Let’s talk if you’re ready to build what lasts.
Opinion
The $128b paradox: Corporate wellness vs women’s burnout
By Katrina Zalcmane, co-founder | partnerships and growth, Véa
The global corporate wellness market reached US$70.65 billion in 2024 and is projected to hit US$128 billion by 2033 – Europe leads the charge, capturing over 39.5 per cent of market share.
Meanwhile, femtech investment hit US$2.2 billion in 2024, representing 8.5 per cent of all digital health funding.
The message is clear: companies recognise that employee wellness matters and women’s health technology is finally getting serious investment.
So why are women still drowning?
In the UK, 91 per cent of adults report experiencing high or extreme stress levels – despite consumers spending an average of US$3,342 annually on wellness and self-care.
60 per cent of women in leadership positions report feeling constantly burned out, while 69 per cent of women feel emotionally drained after every workday.
Around 1 in 4 working women say they can’t manage workplace stress, with only 44 per cent confident their employer even has a burnout plan.
The numbers don’t add up. Billions flowing into wellness programmes. A femtech revolution promising personalised solutions.
And yet women ages 25-45 – the backbone of the modern workforce – are hitting crisis levels of exhaustion.
The problem isn’t a lack of investment – it’s what we’re investing in.
The Mismatch: What Companies Offer vs What Women Actually Need
Health risk assessments captured 21.2 per cent of the European corporate wellness market in 2024, while stress management programmes hold 13 per cent market share and continue expanding.
Companies are checking boxes: biometric screenings, mental health apps, flexible work, meditation subscriptions.
Yet these programmes consistently miss three critical factors:
1. Emotional data is invisible
Modern workplaces reward thinking, problem-solving and constant cognitive output.
What gets lost is the intelligence that comes from recognising early warning signals in the body – somatic indicators that burnout is building long before it becomes visible.
Women are taught to “think through” stress rather than listen to what their bodies are telling them. By the time burnout shows up in productivity metrics or sick days, the damage is done.
2. Hormonal rhythms are ignored
Corporate wellness assumes constant, linear productivity.
But women’s bodies don’t work that way. Menstrual cycles, perimenopause, fertility journeys – all create natural energy fluctuations that impact focus, stress response and cognitive performance.
Instead of working with these rhythms, most women fight against them, blaming themselves for “productivity dips” that are actually biological.
The result is chronic disconnection from their bodies and accelerated burnout.
3. Emotional labour stays uncounted
Women carry disproportionate loads of invisible work – managing team dynamics, mentoring, smoothing conflicts, holding space for others’ stress.
This labour never appears on performance reviews or workload assessments.
It accumulates beneath the surface until women hit a wall.
The Cost of Getting It Wrong
In the UK, mental health-related absences cost the economy approximately £21.6 billion annually, with employees taking 34 million sick days each year due to stress, depression and anxiety.
Employee burnout costs an average 1,000-person company US$5.04 million per year globally. Burned-out employees are 6 times more likely to leave, costing companies 50-200 per cent of salary in recruiting and training.
For women specifically, the crisis deepens.
Women new to leadership report 70 per cent burnout rates; for women of colour in senior positions, it reaches 77 per cent..
Nearly 40 per cent of women actively seeking new jobs cite burnout as the primary reason.
Replacing a mid- or senior-level woman costs up to 213 per cent of her annual salary.
We’re not just losing individual contributors but hemorrhaging the women leaders who hold institutional knowledge, mentor the next generation and drive diversity initiatives.
What Needs to Change
Instead of more generic wellness programs, we need to fundamentally rethink how we support women at work.
1. Shift from crisis response to prevention
Only 44 per cent of women feel confident their employer has a burnout plan – but by then, you’ve already lost.
Companies must teach women to recognise burnout signals in their bodies before a crisis hits. Somatic awareness catches exhaustion early, when intervention still works.
2. Design work around cyclical energy, not constant output
Women need organisational cultures that acknowledge hormonal rhythms as legitimate biological factors affecting performance.
This means training managers to understand energy fluctuations and designing workloads that account for them instead of just offering “flexible arrangements”.
3. Make invisible labour visible
Emotional labor must be quantified, acknowledged and redistributed.
This requires new frameworks for measuring contributions beyond traditional output metrics and structural changes preventing this work from defaulting to women.
4. Prioritise personalisation over one-size-fits-all
Workforce wellness now centres on personalisation powered by AI and data analytics.
A 27-year-old establishing her career has completely different needs than a 42-year-old navigating perimenopause while caring for ageing parents.
AI-driven platforms can deliver tailored support – virtual health assistants, personalised insights, telemedicine – making care more accessible for women balancing careers, family and wellness.
The Opportunity
Closing the women’s health gap could add at least $1 trillion annually to the global economy by 2040.
But unlocking that value requires interventions addressing burnout’s root causes, not just symptoms.
The market is already voting.
Virtual workplace wellness programmes saw substantial growth following the pandemic and Europe continues leading corporate wellness investment.
Companies in the UK and France are implementing AI-driven burnout assessments, hybrid wellness platforms and data-driven mental health monitoring.
Still, investment alone isn’t enough.
The question isn’t whether companies will spend on women’s wellness – they already are.
The question is whether they’ll invest in solutions that actually work: reconnecting women with somatic intelligence before burnout becomes visible, designing around hormonal rhythms rather than fighting them and making invisible labour visible so it can be redistributed.
The companies that do will win the talent war.
The ones that don’t will keep wondering why their best women keep leaving.
About Véa Workshops
Véa offers evidence-based corporate wellness workshops designed specifically for women professionals, addressing the root causes of burnout that traditional programs miss.
Grounded in neuroscience, psychology and somatic awareness, Véa workshops focus on prevention rather than crisis response – teaching women to recognise emotional data and somatic signals, work sustainably with hormonal rhythms and make invisible labor visible.
Available in formats from 45-minute executive sessions to half-day leadership offsites, these workshops support sustainable performance without asking women to step back from ambition.
Learn more at veajournal.app/workshops.
Menopause
Medichecks acquires My Menopause Centre to expand specialist hormone health services
Digital diagnostics company Medichecks has acquired specialist menopause health platform and clinic My Menopause Centre.
The deal is part of Medichecks’ move into clinical services and follows its earlier purchase of Leger Clinic, creating what the company describes as a hormone health offering for women and men across the UK.
Medichecks and My Menopause Centre will combine digital services with clinical governance. The acquisition aims to enhance Medichecks’ ability to deliver integrated testing, diagnosis and ongoing clinical support.
The combined group plans to grow its specialist hormone health services, supporting patients across the UK with clinical care throughout different stages of their hormone health journey.
Helen Marsden, co-founder of Medichecks, said: “At Medichecks, our mission is to make healthcare more accessible, evidence-based and patient-centred.
“Helen and Clare have built an outstanding, clinically credible platform that is transforming menopause care for women across the UK.
“Medichecks now owns two CQC Outstanding-rated clinics, the only clinics in their respective sectors to achieve this rating, and we are deeply committed to delivering safe, compassionate and patient-centric care.
“We’re proud to continue the founders’ legacy while supporting the next stage of growth, ensuring more women can access high-quality menopause care when they need it most.”
The CQC, or Care Quality Commission, is the independent regulator of health and social care in England.
The acquisition supports Medichecks’ plans to make hormone healthcare more accessible by delivering integrated testing, diagnosis and ongoing clinical support for patients across the UK.
Helen Normoyle, co-founder and chief executive of My Menopause Centre, said: “We set out to build something resilient, clinically credible and scalable, not just fast.
“Our mission has always been to make menopause care compassionate, accessible and grounded in evidence. Medichecks shares that vision.
“Their digital platform, commitment to clinical excellence and patient-centred care make them the ideal partner to take My Menopause Centre into its next chapter.
“This milestone reflects not only a strong product, but a remarkable team and community.
“I’m deeply proud of what we’ve built and excited to see My Menopause Centre grow further under Medichecks’ leadership.”
Menopause
Menopause specialist Haver joins Midi Health
Menopause specialist Dr Mary Claire Haver has been appointed as the first chief agewell officer at virtual care clinic Midi Health.
In the role, Dr Haver will work with Midi’s clinical team to develop the AgeWell platform, described as a proactive health model that integrates perimenopause and menopausal care with metabolic health, bone density, brain health and cardiovascular risk assessment.
The platform aims to provide preventative care targeting what the company describes as the primary drivers of female mortality and disability: heart disease, bone loss and cognitive decline.
Joanna Strober, chief executive and co-founder of Midi Health, said: “Longevity care has historically ignored women’s biology, especially during the critical windows of midlife and menopause.
“At Midi Health, we are committed to extending healthspan, not just lifespan, and making that care accessible to millions of women as a core pillar of their health.
“By collaborating with Dr Haver, we are ensuring women continue to have access to care designed for their bodies, their hormones, and their real lives.”
Dr Haver is board-certified in obstetrics and gynaecology, a Menopause Society certified practitioner, a certified culinary medicine specialist and an adjunct associate professor of obstetrics and gynaecology at The University of Texas Medical Branch.
After a career in academic medicine, Dr Haver founded The Pause Life, described as a science and education-based resource for women navigating perimenopause and the menopause transition.
Through her books, unPaused podcast and digital platform, she has provided education on midlife health.
Dr Mary Claire Haver said: “I have spent my career advocating for women to receive the science-backed, no-nonsense guidance they deserve.
“I chose to partner with Midi Health because they are the only platform with the scale and medical rigour to deliver the kind of care women deserve, regardless of their zip codes.
“Together, we are setting a new standard for proactive, preventative care that meaningfully extends both lifespan and healthspan for women.”
-
Insight4 weeks agoDesigner perfumes recalled over banned chemical posing fertility risk
-
Insight2 weeks agoParents sue IVF clinic after delivering someone else’s baby
-
Wellness3 weeks agoWomen’s health could unlock US$100bn by 2030
-
Insight4 weeks agoChina’s birth rate hits record low despite government fertility efforts
-
Menopause3 weeks agoHRT linked to greater weight loss on tirzepatide
-
Entrepreneur6 days agoUS startup builds wearable hormone tracker
-
Menopause2 weeks agoFlo Health and Mayo Clinic publish global perimenopause awareness study
-
News4 weeks agoVerdane invest in Clue to accelerate the future of women’s health






